1515 — China Resources Medical Holdings Share Price
- HK$4.82bn
- HK$7.29bn
- CNY10.11bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 5.78 | ||
PEG Ratio (f) | 0.32 | ||
EPS Growth (f) | 22.41% | ||
Dividend Yield (f) | 5.51% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.77 | ||
Price to Tang. Book | 2.06 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.44 | ||
EV to EBITDA | 5.8 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.32% | ||
Return on Equity | 3.36% | ||
Operating Margin | 5.28% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 2,115.32 | 2,750.65 | 4,447.48 | 7,901.29 | 10,107.5 | 10,983.3 | 11,636.59 | 37.46% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -8.07 | -22.74 | +84.93 | -34.88 | +54.88 | +26.54 | +14.94 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and external customers. The General Healthcare Services segment provides hospital services provided through Jian Gong Hospital and 999 Medical Clinic (Shenzhen) Co., Ltd. The Hospital Management and Consulting Services segment provides comprehensive management and consulting services to IOT Hospitals and sponsored hospitals and receives an annual fee. The Other Hospital-Derived Services segment provides medical consultation service to third parties.
Directors
- Qing Song CHM (56)
- Libing Cheng CEO
- Yuan Ren CFO (45)
- Zechang Xu GMG (54)
- Yanjun Fu EDR (41)
- Baojie Shan EDR (50)
- Qianjin Chen OTH (42)
- Wing Kee Or OTH (46)
- Yiu Fung So SEC (36)
- Hui Hu NED (53)
- Kam Hing Chiu NID (68)
- Kwok Kong Kwong NID
- Kar Chung Lee NID (39)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 28th, 2013
- Public Since
- November 29th, 2013
- No. of Employees
- 20,172
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,296,676,516
- Address
- E-825, BEIJING, 100050
- Web
- http://www.crmedical.hk/
- Phone
- +86 1059361058
- Auditors
- Ernst & Young
Upcoming Events for 1515
Dividend For 1515.HK - 0.0600 CNY
Half Year 2024 China Resources Medical Holdings Company Ltd Earnings Release
Similar to 1515
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:06 UTC, shares in China Resources Medical Holdings are trading at HK$3.72. This share price information is delayed by 15 minutes.
Shares in China Resources Medical Holdings last closed at HK$3.72 and the price had moved by -51.05% over the past 365 days. In terms of relative price strength the China Resources Medical Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -48.91% over the past year.
The overall consensus recommendation for China Resources Medical Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The China Resources Medical Holdings dividend yield is 1.75% based on the trailing twelve month period.
Last year, China Resources Medical Holdings paid a total dividend of CNY0.06, and it currently has a trailing dividend yield of 1.75%. We do not have any data on when China Resources Medical Holdings is to next pay dividends.
We do not have data on when China Resources Medical Holdings is to next pay dividends. The historic dividend yield on China Resources Medical Holdings shares is currently 1.75%.
To buy shares in China Resources Medical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$3.72, shares in China Resources Medical Holdings had a market capitalisation of HK$4.82bn.
Here are the trading details for China Resources Medical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1515
Based on an overall assessment of its quality, value and momentum China Resources Medical Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in China Resources Medical Holdings is HK$7.66. That is 105.92% above the last closing price of HK$3.72.
Analysts covering China Resources Medical Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.57 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Resources Medical Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -26.49%.
As of the last closing price of HK$3.72, shares in China Resources Medical Holdings were trading -23.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Resources Medical Holdings PE ratio based on its reported earnings over the past 12 months is 5.78. The shares last closed at HK$3.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Resources Medical Holdings' management team is headed by:
- Qing Song - CHM
- Libing Cheng - CEO
- Yuan Ren - CFO
- Zechang Xu - GMG
- Yanjun Fu - EDR
- Baojie Shan - EDR
- Qianjin Chen - OTH
- Wing Kee Or - OTH
- Yiu Fung So - SEC
- Hui Hu - NED
- Kam Hing Chiu - NID
- Kwok Kong Kwong - NID
- Kar Chung Lee - NID